171 related articles for article (PubMed ID: 24965284)
1. Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer's disease and vascular dementia.
Alam R; Tripathi M; Mansoori N; Parveen S; Luthra K; Lakshmy R; Sharma S; Arulselvi S; Mukhopadhyay AK
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):769-76. PubMed ID: 24965284
[TBL] [Abstract][Full Text] [Related]
2. Assessment of paraoxonase 1 activity in patients with Alzheimer's disease and vascular dementia.
Agilli M; Aydin FN; Kurt YG; Cayci T
Am J Alzheimers Dis Other Demen; 2015 Aug; 30(5):437-8. PubMed ID: 25635109
[No Abstract] [Full Text] [Related]
3. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
[TBL] [Abstract][Full Text] [Related]
4. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
[TBL] [Abstract][Full Text] [Related]
5. Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
Janka Z; Juhász A; Rimanóczy A A; Boda K; Márki-Zay J; Kálmán J
Mol Psychiatry; 2002; 7(1):110-2. PubMed ID: 11803456
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
7. PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia.
Cervellati C; Romani A; Bergamini CM; Bosi C; Sanz JM; Passaro A; Zuliani G
Clin Chem Lab Med; 2015 Jun; 53(7):1049-56. PubMed ID: 25490030
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia.
Chen JH; Hsieh CJ; Huang YL; Chen YC; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM
J Formos Med Assoc; 2016 Jan; 115(1):38-44. PubMed ID: 25703997
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase activity and dementia.
Wehr H; Bednarska-Makaruk M; Graban A; Lipczyńska-Łojkowska W; Rodo M; Bochyńska A; Ryglewicz D
J Neurol Sci; 2009 Aug; 283(1-2):107-8. PubMed ID: 19268306
[TBL] [Abstract][Full Text] [Related]
11. MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction.
Mansoori N; Tripathi M; Luthra K; Alam R; Lakshmy R; Sharma S; Arulselvi S; Parveen S; Mukhopadhyay AK
Neurobiol Aging; 2012 May; 33(5):1003.e1-8. PubMed ID: 22015309
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia.
Maletta R; Smirne N; Bernardi L; Anfossi M; Gallo M; Conidi ME; Colao R; Puccio G; Curcio SAM; Laganà V; Frangipane F; Cupidi C; Mirabelli M; Vasso F; Torchia G; Muraca MG; Di Lorenzo R; Rose G; Montesanto A; Passarino G; Bruni AC
J Alzheimers Dis; 2018; 61(3):1179-1187. PubMed ID: 29332048
[TBL] [Abstract][Full Text] [Related]
13. LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease.
Cagnin A; Leon A; Vianello D; Colavito D; Favaretto S; Zarantonello G; Stecca A; Ermani M; Zambon A
J Alzheimers Dis; 2013; 34(2):377-85. PubMed ID: 23207490
[TBL] [Abstract][Full Text] [Related]
14. Serum folic acid and RFC A80G polymorphism in Alzheimer's disease and vascular dementia.
Mansoori N; Tripathi M; Alam R; Luthra K; Sharma S; Lakshmy R; Kalaivani M; Mukhopadhyay AK
Am J Alzheimers Dis Other Demen; 2014 Feb; 29(1):38-44. PubMed ID: 24554143
[TBL] [Abstract][Full Text] [Related]
15. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein profile and APOE genotype in Alzheimer's disease.
Cagnin A; Zambon A; Zarantonello G; Vianello D; Marchiori M; Mercurio D; Miccichè F; Ermani M; Leon A; Battistin L
J Neural Transm Suppl; 2007; (72):175-9. PubMed ID: 17982892
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia.
Luthra K; Tripathi M; Grover R; Dwivedi M; Kumar A; Dey AB
Dement Geriatr Cogn Disord; 2004; 17(3):132-5. PubMed ID: 14739533
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.
McCusker SM; Curran MD; Dynan KB; McCullagh CD; Urquhart DD; Middleton D; Patterson CC; McIlroy SP; Passmore AP
Lancet; 2001 Feb; 357(9254):436-9. PubMed ID: 11273064
[TBL] [Abstract][Full Text] [Related]
19. Is apolipoprotein E4 an important risk factor for vascular dementia?
Rohn TT
Int J Clin Exp Pathol; 2014; 7(7):3504-11. PubMed ID: 25120729
[TBL] [Abstract][Full Text] [Related]
20. What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia?
Altamura C; Squitti R; Pasqualetti P; Tibuzzi F; Silvestrini M; Ventriglia MC; Cassetta E; Rossini PM; Vernieri F
Eur J Neurol; 2007 Jun; 14(6):679-82. PubMed ID: 17539949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
